Biomaterial Database

[Materials on the characteristics of live influenza vaccine from influenza virus strains A2-Moscow 21-65, B-Likh and B-95-59]. 1968

S A Parfus, and V M Gagarinova, and G I Karpukhin, and S S Galitarov

UI	MeSH Term	Description	Entries
D007251	Influenza, Human	An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia.	Grippe,Human Flu,Human Influenza,Influenza in Humans,Influenza,Flu, Human,Human Influenzas,Influenza in Human,Influenzas,Influenzas, Human
D007252	Influenza Vaccines	Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed and attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The flu vaccines may be mono- or multi-valent, which contains one or more ALPHAINFLUENZAVIRUS and BETAINFLUENZAVIRUS strains.	Flu Vaccine,Influenzavirus Vaccine,Monovalent Influenza Vaccine,Universal Flu Vaccine,Universal Influenza Vaccine,Flu Vaccines,High-Dose Trivalent Influenza Vaccine,Influenza Vaccine,Influenza Virus Vaccine,Influenza Virus Vaccines,Influenzavirus Vaccines,Intranasal Live-Attenuated Influenza Vaccine,LAIV Vaccine,Monovalent Influenza Vaccines,Quadrivalent Influenza Vaccine,Trivalent Influenza Vaccine,Trivalent Live Attenuated Influenza Vaccine,Universal Flu Vaccines,Universal Influenza Vaccines,Flu Vaccine, Universal,High Dose Trivalent Influenza Vaccine,Influenza Vaccine, Monovalent,Influenza Vaccine, Quadrivalent,Influenza Vaccine, Trivalent,Influenza Vaccine, Universal,Intranasal Live Attenuated Influenza Vaccine,Vaccine, Flu,Vaccine, Influenza,Vaccine, Influenza Virus,Vaccine, Influenzavirus,Vaccine, LAIV,Vaccine, Monovalent Influenza,Vaccine, Quadrivalent Influenza,Vaccine, Trivalent Influenza,Virus Vaccine, Influenza
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014611	Vaccination	Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis.	Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations

Related Publications

S A Parfus, and V M Gagarinova, and G I Karpukhin, and S S Galitarov

[Studies with the influenza virus strain A2 Moscow 57-65].

March 1968, Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. 1. Abt. Medizinisch-hygienische Bakteriologie, Virusforschung und Parasitologie. Originale,

S A Parfus, and V M Gagarinova, and G I Karpukhin, and S S Galitarov

[Studies on live influenza virus vaccine. I. Attenuated influenza A2 Hong Kong virus and its biological and immunological characteristics (author's transl)].

June 1973, Uirusu,

S A Parfus, and V M Gagarinova, and G I Karpukhin, and S S Galitarov

Epidemiologic efficacy of live influenza vaccine during 1962 outbreaks of influenza A2 and B.

January 1966, Federation proceedings. Translation supplement; selected translations from medical-related science,

S A Parfus, and V M Gagarinova, and G I Karpukhin, and S S Galitarov

[Epidemiological efficacy of live influenza vaccine during the A2 and B influenza outbreaks in 1962].

October 1965, Zhurnal mikrobiologii, epidemiologii i immunobiologii,

S A Parfus, and V M Gagarinova, and G I Karpukhin, and S S Galitarov

[Epidemiological effectiveness of live influenza vaccine during A2 and B influenza outbreaks in 1962].

January 1965, Voprosy virusologii,